Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005681 | spliceosomal complex | 3 | 2 |
GO:0005685 | U1 snRNP | 5 | 2 |
GO:0005689 | U12-type spliceosomal complex | 4 | 2 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0097525 | spliceosomal snRNP complex | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0120114 | Sm-like protein family complex | 2 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
Related structures:
AlphaFold database: Q4QEK6
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 2 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 2 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006397 | mRNA processing | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008380 | RNA splicing | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0045292 | mRNA cis splicing, via spliceosome | 9 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 11 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 11 |
GO:0017069 | snRNA binding | 5 | 2 |
GO:0043021 | ribonucleoprotein complex binding | 3 | 2 |
GO:0044877 | protein-containing complex binding | 2 | 2 |
GO:0070990 | snRNP binding | 4 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:1990446 | U1 snRNP binding | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.481 |
CLV_NRD_NRD_1 | 177 | 179 | PF00675 | 0.256 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.330 |
CLV_NRD_NRD_1 | 197 | 199 | PF00675 | 0.274 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.615 |
CLV_PCSK_FUR_1 | 198 | 202 | PF00082 | 0.290 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.495 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 177 | 179 | PF00082 | 0.239 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.285 |
CLV_PCSK_KEX2_1 | 223 | 225 | PF00082 | 0.458 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 47 | 49 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 14 | 16 | PF00082 | 0.477 |
CLV_PCSK_PC1ET2_1 | 200 | 202 | PF00082 | 0.285 |
CLV_PCSK_PC1ET2_1 | 223 | 225 | PF00082 | 0.443 |
CLV_PCSK_PC1ET2_1 | 29 | 31 | PF00082 | 0.496 |
CLV_PCSK_PC7_1 | 10 | 16 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 178 | 182 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 223 | 227 | PF00082 | 0.480 |
CLV_PCSK_SKI1_1 | 264 | 268 | PF00082 | 0.489 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.515 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.710 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.498 |
DEG_SPOP_SBC_1 | 88 | 92 | PF00917 | 0.728 |
DOC_CKS1_1 | 231 | 236 | PF01111 | 0.489 |
DOC_CYCLIN_RxL_1 | 220 | 230 | PF00134 | 0.423 |
DOC_MAPK_gen_1 | 175 | 184 | PF00069 | 0.465 |
DOC_MAPK_gen_1 | 198 | 209 | PF00069 | 0.503 |
DOC_PP1_RVXF_1 | 190 | 197 | PF00149 | 0.531 |
DOC_PP2B_LxvP_1 | 267 | 270 | PF13499 | 0.529 |
DOC_PP4_FxxP_1 | 231 | 234 | PF00568 | 0.468 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.658 |
DOC_USP7_UBL2_3 | 199 | 203 | PF12436 | 0.505 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.522 |
LIG_14-3-3_CanoR_1 | 161 | 166 | PF00244 | 0.427 |
LIG_14-3-3_CanoR_1 | 224 | 232 | PF00244 | 0.455 |
LIG_AP2alpha_1 | 155 | 159 | PF02296 | 0.549 |
LIG_CSL_BTD_1 | 231 | 234 | PF09270 | 0.468 |
LIG_EH_1 | 122 | 126 | PF12763 | 0.541 |
LIG_FHA_2 | 145 | 151 | PF00498 | 0.448 |
LIG_FHA_2 | 241 | 247 | PF00498 | 0.559 |
LIG_LIR_Apic_2 | 229 | 235 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 176 | 187 | PF02991 | 0.530 |
LIG_LIR_Nem_3 | 157 | 162 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.430 |
LIG_LIR_Nem_3 | 183 | 187 | PF02991 | 0.435 |
LIG_Pex14_1 | 28 | 32 | PF04695 | 0.481 |
LIG_Pex14_2 | 155 | 159 | PF04695 | 0.470 |
LIG_REV1ctd_RIR_1 | 30 | 36 | PF16727 | 0.500 |
LIG_SH2_CRK | 205 | 209 | PF00017 | 0.427 |
LIG_SH2_STAP1 | 205 | 209 | PF00017 | 0.427 |
LIG_SH3_3 | 262 | 268 | PF00018 | 0.676 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.493 |
LIG_SH3_3 | 80 | 86 | PF00018 | 0.628 |
LIG_TRAF2_1 | 106 | 109 | PF00917 | 0.573 |
LIG_TRAF2_1 | 147 | 150 | PF00917 | 0.435 |
MOD_CK1_1 | 230 | 236 | PF00069 | 0.578 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.426 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.614 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.625 |
MOD_CK2_1 | 144 | 150 | PF00069 | 0.287 |
MOD_CK2_1 | 240 | 246 | PF00069 | 0.680 |
MOD_GlcNHglycan | 240 | 243 | PF01048 | 0.604 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.613 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.665 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.536 |
MOD_GSK3_1 | 237 | 244 | PF00069 | 0.623 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.660 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.671 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.573 |
MOD_NEK2_1 | 226 | 231 | PF00069 | 0.551 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.644 |
MOD_NEK2_2 | 28 | 33 | PF00069 | 0.601 |
MOD_PK_1 | 161 | 167 | PF00069 | 0.285 |
MOD_PK_1 | 203 | 209 | PF00069 | 0.433 |
MOD_Plk_1 | 6 | 12 | PF00069 | 0.517 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.433 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.564 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.530 |
MOD_SUMO_rev_2 | 74 | 83 | PF00179 | 0.607 |
TRG_DiLeu_BaEn_4 | 6 | 12 | PF01217 | 0.601 |
TRG_DiLeu_BaLyEn_6 | 221 | 226 | PF01217 | 0.421 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.269 |
TRG_ENDOCYTIC_2 | 205 | 208 | PF00928 | 0.436 |
TRG_ER_diArg_1 | 13 | 16 | PF00400 | 0.482 |
TRG_ER_diArg_1 | 177 | 179 | PF00400 | 0.265 |
TRG_NLS_MonoCore_2 | 197 | 202 | PF00514 | 0.347 |
TRG_NLS_MonoExtC_3 | 198 | 203 | PF00514 | 0.402 |
TRG_NLS_MonoExtN_4 | 10 | 17 | PF00514 | 0.583 |
TRG_NLS_MonoExtN_4 | 198 | 204 | PF00514 | 0.347 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5T1 | Leptomonas seymouri | 61% | 96% |
A0A0S4J1P9 | Bodo saltans | 31% | 100% |
A0A1X0NYS6 | Trypanosomatidae | 38% | 100% |
A0A3Q8IAQ7 | Leishmania donovani | 91% | 100% |
A4H8T7 | Leishmania braziliensis | 80% | 100% |
A4HX57 | Leishmania infantum | 91% | 75% |
C9ZVT4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AQX2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5B2N5 | Trypanosoma cruzi | 39% | 100% |